An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma

Completed

• Conditions: Lymphoma, Non Hodgkin

• Registration Number: NCT00097565
• Lead Sponsor: Genentech, Inc.

Brief Summary

This is a prospective, observational, longitudinal, multicenter study of patients with newly diagnosed follicular Non Hodgkin's Lymphoma (NHL) designed to delineate differences in clinical outcome by comparing the effectiveness and safety of common treatment regimens.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-03
• Study First Submitted: 2004-11-24
• Study First Submitted QC: 2004-11-24
• Study First Posted: 2004-11-25
• Primary Completion: 2014-03
• Study Completion: 2014-03
• Status Verified: 2017-03
• Last Update Submitted: 2017-03-21
• Last Update Posted: 2017-03-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2740

Inclusion Criteria

• Signed Informed Consent Form (unless the Institutional Review Board [IRB] has granted a waiver of consent)
• Signed Authorization for the Use and Disclosure of Health Information document
• Age ≥18 years
• Histologic documentation of follicular NHL, according to Revised European-American Lymphoma (REAL) classification system, as assessed by the local pathologist and treating physician
• Initial diagnosis of follicular B-cell NHL within 6 months prior to enrollment
• Availability of cancer-specific historical data points in the patient's medical records

Exclusion Criteria

• Other indolent or histologic NHL subtypes
• Diagnosis of lymphoma > 6 months prior to enrollment

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified